These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features. Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644 [TBL] [Abstract][Full Text] [Related]
3. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker. Vilming Elgaaen B; Olstad OK; Haug KB; Brusletto B; Sandvik L; Staff AC; Gautvik KM; Davidson B BMC Cancer; 2014 Feb; 14():80. PubMed ID: 24512620 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer. Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer. Gao YC; Wu J Tumour Biol; 2015 Jun; 36(6):4843-50. PubMed ID: 25636451 [TBL] [Abstract][Full Text] [Related]
6. Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer. Kan CW; Hahn MA; Gard GB; Maidens J; Huh JY; Marsh DJ; Howell VM BMC Cancer; 2012 Dec; 12():627. PubMed ID: 23272653 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer. Cao Q; Lu K; Dai S; Hu Y; Fan W Int J Clin Exp Pathol; 2014; 7(5):2392-401. PubMed ID: 24966949 [TBL] [Abstract][Full Text] [Related]
8. Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma. Zhou J; Gong G; Tan H; Dai F; Zhu X; Chen Y; Wang J; Liu Y; Chen P; Wu X; Wen J Oncol Rep; 2015 Jun; 33(6):2915-23. PubMed ID: 25962395 [TBL] [Abstract][Full Text] [Related]
9. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections. Marchini S; Cavalieri D; Fruscio R; Calura E; Garavaglia D; Fuso Nerini I; Mangioni C; Cattoretti G; Clivio L; Beltrame L; Katsaros D; Scarampi L; Menato G; Perego P; Chiorino G; Buda A; Romualdi C; D'Incalci M Lancet Oncol; 2011 Mar; 12(3):273-85. PubMed ID: 21345725 [TBL] [Abstract][Full Text] [Related]
10. miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations. Teng Y; Su X; Zhang X; Zhang Y; Li C; Niu W; Liu C; Qu K Oncotarget; 2016 Dec; 7(49):81621-81633. PubMed ID: 27835595 [TBL] [Abstract][Full Text] [Related]
11. Ovarian Cancer: Differentially Expressed microRNAs in Tumor Tissue and Cell-Free Ascitic Fluid as Potential Novel Biomarkers. Záveský L; Jandáková E; Weinberger V; Minář L; Hanzíková V; Dušková D; Drábková LZ; Hořínek A Cancer Invest; 2019; 37(9):440-452. PubMed ID: 31530033 [TBL] [Abstract][Full Text] [Related]
12. Circulating Cell-Free miR-373, miR-200a, miR-200b and miR-200c in Patients with Epithelial Ovarian Cancer. Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H Adv Exp Med Biol; 2016; 924():3-8. PubMed ID: 27753009 [TBL] [Abstract][Full Text] [Related]
13. The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer. Wang W; Yin Y; Shan X; Zhou X; Liu P; Cao Q; Zhu D; Zhang J; Zhu W Am J Med Sci; 2019 Oct; 358(4):256-267. PubMed ID: 31353030 [TBL] [Abstract][Full Text] [Related]
14. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis. Cui Y; Hong S; Zhu X Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275 [TBL] [Abstract][Full Text] [Related]
15. Extracellular microRNA profiling for prognostic prediction in patients with high-grade serous ovarian carcinoma. Yoshida K; Yokoi A; Matsuzaki J; Kato T; Ochiya T; Kajiyama H; Yamamoto Y Cancer Sci; 2021 Dec; 112(12):4977-4986. PubMed ID: 34618992 [TBL] [Abstract][Full Text] [Related]
16. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer. Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic potential of differentially regulated microRNAs among endometriosis, endometrioid ovarian cancer, and endometrial cancer. Kumari P; Sharma I; Saha SC; Srinivasan R; Minhas P J Cancer Res Ther; 2021; 17(4):1003-1011. PubMed ID: 34528556 [TBL] [Abstract][Full Text] [Related]
18. Characterization of miR-200 family members as blood biomarkers for human and laying hen ovarian cancer. Choi PW; Bahrampour A; Ng SK; Liu SK; Qiu W; Xie F; Kuo WP; Kwong J; Hales KH; Hales DB; Wong KK; Norwitz ER; Chow CK; Berkowitz RS; Ng SW Sci Rep; 2020 Nov; 10(1):20071. PubMed ID: 33208870 [TBL] [Abstract][Full Text] [Related]
19. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428 [TBL] [Abstract][Full Text] [Related]
20. The differential expression of miRNAs between ovarian endometrioma and endometriosis-associated ovarian cancer. Nakamura N; Terai Y; Nunode M; Kokunai K; Konishi H; Taga S; Nakamura M; Yoo M; Hayashi M; Yamashita Y; Ohmichi M J Ovarian Res; 2020 May; 13(1):51. PubMed ID: 32359364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]